Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 3Malignant Female Reproductive System Neoplasm 2Rectal Neoplasms 1Pulmonary Nodule 1Pain, Postoperative 1Neoplasms 1Ileus 1Hematologic Neoplasms 1Emergencies 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Cancer Pain 1Agnosia 1

Interventions

Oxycodone 9Fentanyl 5Morphine 3Ethanol 3Naloxone 2Buprenorphine 2Acetaminophen 2rofecoxib 1Ultracet 1Radiofrequency Ablation 1Polyethylene Glycols 1Methadone 1Magnesium Hydroxide 1Hydromorphone 1Electrolytes 1Duration of Therapy 1Dosage Forms 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Cancer Pain × Hydromorphone × Clear all
NCT00766831 2013-10-23

An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain

Janssen Korea, Ltd., Korea

Phase 4 Completed
190 enrolled 17 charts

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡